Home › Funds › MAVERICK CAPITAL LTD › PCVX

MAVERICK CAPITAL LTD position in PCVX

VAXCYTE INC · Health Care

MAVERICK CAPITAL LTD reported holding 1,613,242 shares of PCVX (VAXCYTE INC) in its Q2 2026 13F filing — a position valued at US$93.8M, representing 0.87% of its reported portfolio and ranking #37 among its reported holdings. MAVERICK CAPITAL LTD has disclosed PCVX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)1.61M sh
Reported value held$93.78M
Portfolio Weight0.87%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MAVERICK CAPITAL LTD's PCVX position evolved

MAVERICK CAPITAL LTD first disclosed a stake in PCVX in Q1 2024 at 355,131 shares (US$24.3M). The position peaked in Q3 2024 at 976,249 shares, worth US$111.6M. Across 10 filings, MAVERICK CAPITAL LTD increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,613,242 shares valued at US$93.8M — an increase of 235,504 shares quarter over quarter.. Notable position changes include a 94% increase in Q2 2024 (shares rose 51% over the following quarter), a 42% increase in Q3 2024 (shares fell 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 355.13K $24.26M New
Q2 2024 687.91K $51.94M Add
Q3 2024 976.25K $111.56M Add
Q4 2024 1.20M $98.39M Add
Q1 2025 1.21M $45.62M Add
Q2 2025 1.31M $42.61M Add
Q3 2025 1.29M $46.45M Reduce
Q4 2025 1.35M $62.48M Add
Q1 2026 1.38M $80.06M Add
Q2 2026 1.61M $93.78M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PCVX and 13F data

PCVX (VAXCYTE INC) is a Health Care company. 35 other funds we track also report a position in PCVX — the largest reported positions include Jupiter Topco LLC (US$1.04B), Janus Henderson Group (US$960.2M), T. Rowe Price Investment Management, Inc. (US$709.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PCVX

All PCVX fund holders →

FAQ

How long has MAVERICK CAPITAL LTD held PCVX?

MAVERICK CAPITAL LTD has disclosed PCVX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is MAVERICK CAPITAL LTD's current position in PCVX?

As of Q2 2026, MAVERICK CAPITAL LTD holds 1.61M shares of PCVX (VAXCYTE INC), valued at $93.78M, representing 0.87% of its reported portfolio and ranking #37.

Has MAVERICK CAPITAL LTD been buying or selling PCVX?

In the latest 13F filing (Q2 2026), MAVERICK CAPITAL LTD increased its position in PCVX. The position peaked in Q3 2024 at 976.25K shares.

Which other funds hold PCVX?

Other major institutional holders of PCVX include Jupiter Topco LLC, Janus Henderson Group, T. Rowe Price Investment Management, Inc., among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.